Medtronic Cofounder Earl Bakken Dies

 

October 21, 2018—Medtronic announced that its Cofounder Earl E. Bakken passed away peacefully on October 21, 2018 at his home on Kiholo Bay on the Big Island of Hawaii. He was 94.

Omar Ishrak, Medtronic Chairman and Chief Executive Officer, stated, "Today we are saddened by the passing of Earl Bakken, but we also honor and will forever cherish the life of a beloved man whose brilliance and vision have improved the lives of millions of people around the world. The contributions Earl made to the field of medical technology simply cannot be overstated. His spirit will live on with us as we work to fulfill the mission he wrote nearly 60 years ago—to alleviate pain, restore health, and extend life. Our thoughts and prayers are with the Bakken family during this difficult time."

In 1949, Mr. Bakken founded Medtronic with his brother-in-law, Palmer J. Hermundslie. He led the company for 40 years, guiding it from humble roots into one of the world's premier medical technology companies. He retired as Chairman in 1989.

Medtronic's full statement is available on the company's website here.

An appreciation entitled "Celebrating Earl Bakken," featuring remembrances and photographs, is available here.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.